Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate treatment of advanced Parkinson's Disease (PD) patients on levodopa-carbidopa intestinal gel (LCIG) monotherapy in a routine clinical setting.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
AbbVie
NCT07310264 · Healthy Volunteers (HV), Parkinson's Disease (PD)
NCT07316296 · Parkinson's Disease (PD), Freezing of Gait, and more
NCT07417280 · Parkinson's Disease (PD), Essential Tremor, and more
NCT06107426 · Parkinson's Disease (PD)
NCT07533591 · Parkinson's Disease (PD)
Gailtal Klinik /ID# 202505
Hermagor-Pressegger See, Carinthia
Medizinische Universität Graz /ID# 202559
Graz, Styria
University of Calgary /ID# 206550
Calgary, Alberta
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions